This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Tetroxoprim" – news · newspapers · books · scholar · JSTOR (August 2014) (Learn how and when to remove this template message)
Tetroxoprim
Clinical data
ATC code
Identifiers
  • 5-[3,5-Dimethoxy-4-(2-methoxyethoxy)benzyl]pyrimidine-2,4-diamine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.053.427 Edit this at Wikidata
Chemical and physical data
FormulaC16H22N4O4
Molar mass334.376 g·mol−1
3D model (JSmol)
  • COCCOC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC
  • InChI=1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20) ☒N
  • Key:WSWJIZXMAUYHOE-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Tetroxoprim (INN) is a derivative of trimethoprim. It was first described in 1979.[1][2][3]

Its chemical formula is C=16 | H=22 | N=4 | O=4. [2][3]

References

  1. ^ Aschhoff HS, Vergin H (November 1979). "Tetroxoprim—a new inhibitor of bacterial dihydrofolate reductase". J Antimicrob Chemother. 5 (B): 19–25. doi:10.1093/jac/5.supplement_b.19. PMID 43863.
  2. ^ a b "Tetroxoprim". pubchem.ncbi.nlm.nih.gov.
  3. ^ a b "Tetroxoprim - an overview | ScienceDirect Topics". www.sciencedirect.com.


Categories